Semaglutide has emerged as a novel treatment for insulin resistance. This manufactured glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to produce more insulin and curbing glucagon https://elainedaee453455.articlesblogger.com/58077794/understanding-semaglutide-a-comprehensive-guide